TCRX logo

TScan Therapeutics (TCRX) Free Cash Flow

Annual FCF

-$114.65 M
-$50.14 M-77.74%

December 31, 2024


Summary


Performance

TCRX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTCRXcash flowmetrics:

Quarterly FCF

-$28.30 M
+$988.00 K+3.37%

December 31, 2024


Summary


Performance

TCRX Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTCRXcash flowmetrics:

TTM FCF

-$114.65 M
-$4.07 M-3.68%

December 31, 2024


Summary


Performance

TCRX TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTCRXcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

TCRX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-77.7%0.0%0.0%
3 y3 years-95.6%-528.9%-98.8%
5 y5 years-732.6%-528.9%-98.8%

TCRX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-95.6%at low-528.9%+5.6%-98.8%at low
5 y5-year-1478.9%at low-289.6%+5.6%-1432.2%at low
alltimeall time-1478.9%at low-289.6%+5.6%-1432.2%at low

TScan Therapeutics Free Cash Flow History

DateAnnualQuarterlyTTM
Dec 2024
-$114.65 M(+77.7%)
-$28.30 M(-3.4%)
-$114.65 M(+3.7%)
Sep 2024
-
-$29.29 M(+8.1%)
-$110.58 M(+48.0%)
Jun 2024
-
-$27.09 M(-9.6%)
-$74.70 M(+6.6%)
Mar 2024
-
-$29.97 M(+23.7%)
-$70.05 M(+8.6%)
Dec 2023
-$64.50 M(-8.8%)
-$24.23 M(-467.3%)
-$64.50 M(+11.9%)
Sep 2023
-
$6.60 M(-129.4%)
-$57.66 M(-29.4%)
Jun 2023
-
-$22.44 M(-8.1%)
-$81.68 M(+9.6%)
Mar 2023
-
-$24.43 M(+40.5%)
-$74.50 M(+5.3%)
Dec 2022
-$70.73 M
-$17.39 M(-0.2%)
-$70.73 M(+1.1%)
Sep 2022
-
-$17.43 M(+14.2%)
-$69.93 M(+4.4%)
Jun 2022
-
-$15.26 M(-26.1%)
-$67.00 M(+1.0%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$20.66 M(+24.5%)
-$66.36 M(+13.2%)
Dec 2021
-$58.62 M(+707.3%)
-$16.59 M(+14.5%)
-$58.62 M(+15.5%)
Sep 2021
-
-$14.49 M(-0.9%)
-$50.76 M(+17.0%)
Jun 2021
-
-$14.62 M(+13.2%)
-$43.40 M(+213.1%)
Mar 2021
-
-$12.92 M(+47.9%)
-$13.86 M(+90.9%)
Dec 2020
-$7.26 M(-47.3%)
-
-
Dec 2020
-
-$8.73 M(+22.5%)
-$7.26 M(-592.6%)
Sep 2020
-
-$7.13 M(-147.8%)
$1.47 M(-82.9%)
Jun 2020
-
$14.92 M(-336.3%)
$8.61 M(-236.3%)
Mar 2020
-
-$6.32 M
-$6.32 M
Dec 2019
-$13.77 M
-
-

FAQ

  • What is TScan Therapeutics annual free cash flow?
  • What is the all time high annual FCF for TScan Therapeutics?
  • What is TScan Therapeutics annual FCF year-on-year change?
  • What is TScan Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for TScan Therapeutics?
  • What is TScan Therapeutics quarterly FCF year-on-year change?
  • What is TScan Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for TScan Therapeutics?
  • What is TScan Therapeutics TTM FCF year-on-year change?

What is TScan Therapeutics annual free cash flow?

The current annual FCF of TCRX is -$114.65 M

What is the all time high annual FCF for TScan Therapeutics?

TScan Therapeutics all-time high annual free cash flow is -$7.26 M

What is TScan Therapeutics annual FCF year-on-year change?

Over the past year, TCRX annual free cash flow has changed by -$50.14 M (-77.74%)

What is TScan Therapeutics quarterly free cash flow?

The current quarterly FCF of TCRX is -$28.30 M

What is the all time high quarterly FCF for TScan Therapeutics?

TScan Therapeutics all-time high quarterly free cash flow is $14.92 M

What is TScan Therapeutics quarterly FCF year-on-year change?

Over the past year, TCRX quarterly free cash flow has changed by $0.00 (0.00%)

What is TScan Therapeutics TTM free cash flow?

The current TTM FCF of TCRX is -$114.65 M

What is the all time high TTM FCF for TScan Therapeutics?

TScan Therapeutics all-time high TTM free cash flow is $8.61 M

What is TScan Therapeutics TTM FCF year-on-year change?

Over the past year, TCRX TTM free cash flow has changed by $0.00 (0.00%)